Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Site search
Search
Menu
Search
Subscribe
Home
Contact Us
Subscription Services
Promote Your Event
e-Edition
News
Sports
Entertainment
Obituaries
Photos
Videos
e-Edition
Classifieds
Place an Ad
Best of 2022
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Vertex Pharmaceuticals
(NQ:
VRTX
)
350.92
+0.25 (+0.07%)
Streaming Delayed Price
Updated: 11:47 AM EDT, Sep 26, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vertex Pharmaceuticals
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
This Is What Whales Are Betting On Vertex Pharmaceuticals
September 25, 2023
Via
Benzinga
Buying These 2 Remarkable Growth Stocks in Any Market Could Be a Genius Move
September 25, 2023
Great companies haven't gone anywhere.
Via
The Motley Fool
3 Magnificent Growth Stocks to Buy Right Now
September 24, 2023
If you're looking for growth, these stocks could be just the ticket.
Via
The Motley Fool
Meta Stock Leads 5 Names Showing Resilience In Market Downturn
September 23, 2023
These stocks have held up so far, but patience is key amid the correction.
Via
Investor's Business Daily
Price Over Earnings Overview: Vertex Pharmaceuticals
September 22, 2023
Via
Benzinga
2 Healthcare Stocks That Could Make You Richer
September 22, 2023
They've beaten the market before.
Via
The Motley Fool
Is NASDAQ:VRTX suited for quality investing?
September 15, 2023
Reasonable growth and debt and a high ROIC for VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX).
Via
Chartmill
Could These Be Vertex Pharmaceuticals' Most Promising Candidates?
September 08, 2023
The biotech has no shortage of promising pipeline programs.
Via
The Motley Fool
Expert Ratings for Vertex Pharmaceuticals
September 07, 2023
Via
Benzinga
3 Unstoppable Stocks to Buy and Hold for the Next 20 Years
September 21, 2023
These stocks are great long-term picks.
Via
The Motley Fool
Where Will CRISPR Therapeutics Be in 5 Years?
September 19, 2023
The company hasn't performed well in the past five years, but things could change.
Via
The Motley Fool
2 Top Trends to Invest $500 In Right Now
September 18, 2023
Early investors in these trends may reap the rewards over time.
Via
The Motley Fool
Here's the 1 Cathie Wood Stock Most Likely to Turn $100,000 Into $1 Million Over the Next 20 Years
September 17, 2023
There's no guarantee that any stock will be a millionaire-maker. But the chances for this one look pretty good.
Via
The Motley Fool
Looking for Growth? These Companies' Revenue May Skyrocket
September 17, 2023
Catalysts on the horizon could drive gains in these top stocks.
Via
The Motley Fool
If You Invested $30,000 in CRISPR Therapeutics in 2016, This Is How Much You Would Have Today
September 16, 2023
The returns are impressive, but will they continue to be so?
Via
The Motley Fool
Looking Into Vertex Pharmaceuticals's Recent Short Interest
September 06, 2023
Via
Benzinga
Here's How Much $1000 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth Today
September 15, 2023
Via
Benzinga
Vertex Receives CHMP Positive Opinion for KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in Combination With Ivacaftor for Children With Cystic Fibrosis Ages 2 Through 5
September 15, 2023
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Have Million-Dollar Gene Therapies Finally Reached An Inflection Point?
September 15, 2023
Gene therapies are clearing the FDA and reaching seriously ill patients. They could cost millions.
Via
Investor's Business Daily
Exposures
Product Safety
3 Top Healthcare Stocks Defying the Bear Market
September 15, 2023
Revenue at all three companies improved last quarter, and their share prices have followed suit.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
September 14, 2023
Via
Benzinga
Vertex Researchers Awarded 2024 Breakthrough Prize in Life Sciences
September 14, 2023
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Better Bull Market Buy: CRISPR vs. Medtronic Stock
September 14, 2023
Investors may look for growth stocks ahead of the next bull market.
Via
The Motley Fool
A Bull Market Is (Still) Coming: Here Are 3 Spectacular Stocks to Buy Sooner Rather Than Later
September 10, 2023
These stocks should be even bigger winners than they already are when a new bull market takes hold.
Via
The Motley Fool
3 Unstoppable Growth Stocks to Buy Right Now
September 09, 2023
These healthcare stocks show no signs of slowing down.
Via
The Motley Fool
1 Top Pharma Growth Stock to Buy Today and Hold Forever
September 08, 2023
Vertex's encouraging mix of recurring revenue and growth make it a leader.
Via
The Motley Fool
2 Top Biotech Stocks to Buy in September
September 08, 2023
There is rarely a bad time to buy stocks with massive upside potential.
Via
The Motley Fool
September Rally? 3 Stocks to Buy Before Liftoff
September 08, 2023
September has the reputation as the worst performing month of the year, but these are stocks to buy now in anticipation of the rally to come.
Via
InvestorPlace
3 Must-Know Tricks for Investing in Big Pharma Stocks
September 08, 2023
Using these tricks will help you appreciate where and when to invest.
Via
The Motley Fool
CRSP Stock Alert: What to Know as CRISPR Therapeutics Co-Founder Steps Down
September 07, 2023
With CRISPR Therapeutics announcing the departure of its co-founder, investors are also walking for the exits on CRSP stock.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.